Vinyl neodecanoate
General Information
Mainterm | Vinyl neodecanoate |
CAS Reg.No.(or other ID) | 51000-52-3 |
Regnum |
From www.fda.gov
Computed Descriptors
Download SDF2D Structure | |
CID | 162097 |
IUPAC Name | ethenyl 7,7-dimethyloctanoate |
InChI | InChI=1S/C12H22O2/c1-5-14-11(13)9-7-6-8-10-12(2,3)4/h5H,1,6-10H2,2-4H3 |
InChI Key | TVFJAZCVMOXQRK-UHFFFAOYSA-N |
Canonical SMILES | CC(C)(C)CCCCCC(=O)OC=C |
Molecular Formula | C12H22O2 |
Wikipedia | vinyl neodecanoate |
From Pubchem
Computed Properties
Property Name | Property Value |
---|---|
Molecular Weight | 198.306 |
Hydrogen Bond Donor Count | 0 |
Hydrogen Bond Acceptor Count | 2 |
Rotatable Bond Count | 8 |
Complexity | 177.0 |
CACTVS Substructure Key Fingerprint | A A A D c e B w M A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A G g A A A A A A D g C g g A I C C A A A B A C I A A C S C A A A C A A A A A A I A A E A A A A A A B I A A A A A A A A E A A A A A A G I y O C N A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A = = |
Topological Polar Surface Area | 26.3 |
Monoisotopic Mass | 198.162 |
Exact Mass | 198.162 |
XLogP3 | None |
XLogP3-AA | 4.2 |
Compound Is Canonicalized | True |
Formal Charge | 0 |
Heavy Atom Count | 14 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Isotope Atom Count | 0 |
Covalently-Bonded Unit Count | 1 |
From Pubchem
ADMET Predicted Profile --- Classification
Model | Result | Probability |
---|---|---|
Absorption | ||
Blood-Brain Barrier | BBB+ | 0.9877 |
Human Intestinal Absorption | HIA+ | 0.9792 |
Caco-2 Permeability | Caco2+ | 0.7072 |
P-glycoprotein Substrate | Non-substrate | 0.6196 |
P-glycoprotein Inhibitor | Non-inhibitor | 0.7364 |
Inhibitor | 0.5230 | |
Renal Organic Cation Transporter | Non-inhibitor | 0.9013 |
Distribution | ||
Subcellular localization | Mitochondria | 0.4461 |
Metabolism | ||
CYP450 2C9 Substrate | Non-substrate | 0.8387 |
CYP450 2D6 Substrate | Non-substrate | 0.9035 |
CYP450 3A4 Substrate | Substrate | 0.5216 |
CYP450 1A2 Inhibitor | Non-inhibitor | 0.5881 |
CYP450 2C9 Inhibitor | Non-inhibitor | 0.8566 |
CYP450 2D6 Inhibitor | Non-inhibitor | 0.9487 |
CYP450 2C19 Inhibitor | Non-inhibitor | 0.8083 |
CYP450 3A4 Inhibitor | Non-inhibitor | 0.8892 |
CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.9176 |
Excretion | ||
Toxicity | ||
Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9469 |
Non-inhibitor | 0.9117 | |
AMES Toxicity | Non AMES toxic | 0.9463 |
Carcinogens | Carcinogens | 0.6076 |
Fish Toxicity | High FHMT | 0.9950 |
Tetrahymena Pyriformis Toxicity | High TPT | 0.9990 |
Honey Bee Toxicity | High HBT | 0.8305 |
Biodegradation | Not ready biodegradable | 0.8741 |
Acute Oral Toxicity | III | 0.9337 |
Carcinogenicity (Three-class) | Non-required | 0.5692 |
From admetSAR
ADMET Predicted Profile --- Regression
Model | Value | Unit |
---|---|---|
Absorption | ||
Aqueous solubility | -4.5886 | LogS |
Caco-2 Permeability | 1.2129 | LogPapp, cm/s |
Distribution | ||
Metabolism | ||
Excretion | ||
Toxicity | ||
Rat Acute Toxicity | 1.6696 | LD50, mol/kg |
Fish Toxicity | -0.1441 | pLC50, mg/L |
Tetrahymena Pyriformis Toxicity | 1.2916 | pIGC50, ug/L |
From admetSAR
Taxonomic Classification
Kingdom | Organic compounds |
---|---|
Superclass | Lipids and lipid-like molecules |
Class | Fatty Acyls |
Subclass | Fatty acid esters |
Intermediate Tree Nodes | Not available |
Direct Parent | Fatty acid esters |
Alternative Parents | |
Molecular Framework | Aliphatic acyclic compounds |
Substituents | Fatty acid ester - Enol ester - Carboxylic acid ester - Monocarboxylic acid or derivatives - Carboxylic acid derivative - Organic oxygen compound - Organic oxide - Hydrocarbon derivative - Organooxygen compound - Carbonyl group - Aliphatic acyclic compound |
Description | This compound belongs to the class of organic compounds known as fatty acid esters. These are carboxylic ester derivatives of a fatty acid. |
From ClassyFire